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REPLY
We thank Kok, Umans, and Arnold for their statistical calcula-
tions. Indeed, a large sample size would be required to prove that
there is equivalence in clinical outcome between patients directly
admitted compared to transferred patients. To demonstrate that
the six-month mortality rate would not exceed more than 1% (6%
vs. 7%) would require a sample size of even more than 25,000
patients! However, it was not our objective to prove that trans-
ferred patients have an identical clinical outcome compared with
directly admitted patients. The “primary endpoints” of this analysis
were variables such as ejection fraction, enzymatic infarct size and
patency rate. For completeness, six-month mortality and reinfarct
rates were reported, demonstrating that the delay was indeed not
associated with a strong increase of adverse events. However, we
emphasize the importance of the patency rate achieved in the
referral patients for longterm survival (1,2), and therefore, our data
are compatible with equivalence in clinical outcome, albeit without
the statistical proof.
The second question regards data on the subgroup of patients
admitted between 3 h and 6 h following onset of symptoms. As
described in our article, one of the characteristics of referral
patients is the short delay between onset of symptoms and
admission. This is probably caused by the criteria used by referral
cardiologists for the decision to transport the patient for primary
angioplasty. In the study group, therefore, only 43 patients
presented between 3 h to 6 h following onset of symptoms. This
subset of patients is too small to be separately evaluated.
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Seasonal Distribution of Myocardial
Infarction and Seasonal Mood Changes
I read with interest the article by Spencer et al. on the seasonal
distribution of acute myocardial infarction (1). I would like to offer
some comments on this article.
Since ancient times, people have known about the seasonal
changes in mood and behavior (2). Seasonal changes in mood were
later described by Esquirol in 1845 (3) and by Kraepelin in 1921
(4). In 1984, the syndrome of “seasonal affective disorder,” a
condition where depressions in fall and winter alternate with
nondepressed periods in the spring and summer, was described (5).
Sadness, anxiety, irritability, decreased activity, difficulties at work,
social withdrawal, changes in appetite, decreased libido and
changes in sleep are characteristic symptoms of winter depression.
The degree to which seasonal changes influence mood, energy,
sleep, appetite, food preference or the wish to socialize with other
people has been called “seasonality” (6). Seasonality can manifest
itself to a different degree in different individuals. Some people
experience only very mild seasonal changes, and others are severely
influenced. Surveys have shown that 25% of the general population
in New York City and 27% of the general population in Mont-
gomery County, Maryland, noted that seasonal changes were a
problem in their lives (6,7). Recent studies have demonstrated that
seasonal mood changes are related to the genetic factors (8). It
means that people may have genetically determined sensitivity to
seasons.
Psychological factors have a very considerable effect on the
cardiovascular system (9–12). Many studies have documented
increased cardiovascular morbidity and mortality in patients with
depressive disorders. Depression has been implicated as an inde-
pendent risk factor in the pathophysiologic progression of cardio-
vascular disease. Depression, stress, anger, anxiety and social
isolation have been shown to substantially increase risk for myo-
cardial infarction in patients diagnosed with coronary artery
disease. Therefore, I suggest that seasonal mood changes may play
a part in the observed seasonal differences in the incidence of
myocardial infarction.
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Left Ventricular
Hypertrophy and Sudden Death
Haider et al. (1) and the editorial by Frohlich (2) remind us of the
poor prognosis conferred by left ventricular hypertrophy (LVH) in
hypertensive subjects. They accurately point out that much work
still remains to be done to elucidate the mechanisms by which
LVH leads to sudden cardiac death and other adverse conse-
quences.
Although considerable research has been directed at cardiac
ultrastructure, electrophysiology and the coronary microcirculation
in LVH, the relationship between hemorheology and hypercoagu-
lability in hypertension, especially if LVH is present, has been
relatively neglected. Although the blood vessels are exposed to
high pressures in hypertension, the main complications of hyper-
tension and LVH (that is, stroke and myocardial infarction) are
paradoxically thrombotic rather than hemorrhagic (3). Indeed, the
hypothesis that hypertension and LVH may confer a hypercoag-
ulable state can be examined by careful reference to Virchow’s triad
(3).
In a high proportion of patients suffering sudden death, post-
mortem examination demonstrates the immediate cause to be
thrombotic occlusion of a major epicardial coronary artery (4).
Indeed, a number of hemorheologic and thrombotic markers have
been shown to be significantly related to, and predictive of,
(thrombotic) cardiovascular events in hypertension (3,5). In keep-
ing with Virchow’s triad for thrombus formation (thrombogen-
esis), patients with hypertension demonstrate abnormalities of
vessel wall (endothelial dysfunction or damage), blood constituents
(abnormal levels of hemostatic factors, platelet activation and
fibrinolysis) and blood flow (rheology and flow reserve), suggesting
that hypertension does confer a prothrombotic or hypercoagulable
state (3). These components appear to be related to target organ
damage and long-term prognosis, and are altered by treatment.
In the Leigh general practice study, for example, hypertensive
subjects with plasma fibrinogen levels .3.5 g/l had a 12-fold
higher cardiovascular risk than those with plasma fibrinogen levels
,2.9 g/l (5). We recently reported that hypertensive patients with
LVH had higher plasma fibrinogen levels compared with those
without LVH; fibrinogen levels were also significantly correlated
with left ventricular mass, left ventricular mass index and left atrial
size (6). Hemorheologic abnormalities, such as increases in whole
blood viscosity or fibrinogen, may account for the reduced coronary
flow noted in LVH.
We believe that further study of hemorheology and hyperco-
agulability in hypertension and of the relationship to LVH would
increase our understanding of the mechanisms by which LVH
leads to sudden death. The main mechanisms for sudden death in
LVH are unlikely to be simply electrophysiologic or arrhythmo-
genic, as suggested by Frolich (2), but are also very likely to be
thrombotic in origin.
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To Trust or Not To Trust
I am writing in response to two articles recently published by
Watanabe et al. (1,2) in the Journal. The accompanying editorial
(3) highlights the fact that there is debate within the scientific
community concerning the results published by this group of
investigators.
These articles are the latest in a series examining pharmacologic
interventions aimed at preventing nitrate tolerance. The interven-
tions range from angiotensin-converting-enzyme inhibition to
vitamin C, vitamin E and now, carvedilol (1,2,4–9). Measures of
nitrate effects include platelet cyclic GMP responses along with
vascular effects documented by blood pressure and forearm pleth-
ysmography. The results in each case have been striking, with
definitive prevention of tolerance across experimental groups that
include normal volunteers, patients with coronary disease and
those with congestive heart failure. The experimental results are
enviable, with closely matched treatment groups (despite small
sample sizes) and highly consistent results in response to the
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